Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,125.4
-14.2 (-0.45%)

 

  • STI Straits Times Index
    3,125.4
    -14.2 (-0.45%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,573.8
    -4.5 (-0.28%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,436.8
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,518.3
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,959.9
    -331.1 (-1.13%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,078.6
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 228.1M
  • Value: 206.3M
  • Rise: 66
  • Fall: 119
  • Unch: 578

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.199+0.009
MarcoPolo Marine0.030-
OTS Holdings0.285+0.285
SinoCloud0.001-
Sembcorp Marine0.195-0.001
YZJ Shipbldg SGD1.390-0.010
Chasen0.067+0.003
Hong Lai Huat0.100+0.003
Asian Micro0.010+0.001
ComfortDelGro1.650-

World Indices

World Indices
Name Last Change
Nasdaq 14,039.7 -33.2
HSI 28,436.8
HSCEI 10,563.0
Jakarta 6,078.6
Nikkei 225 28,959.9 -331.1
SSE Comp 3,518.3
Shanghai A 3,687.8
Shanghai B 252.8
KOSPI 3,255.9 -22.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SUPERMX SUPERMAX CORPORATION BHD
Quotes 15 Minutes Delayed. Updated at 17 Jun 2021 09:18
Last (MYR): 3.660 Change: -0.040 High: 3.700 Remarks:
Change (%): -1.08 Low: 3.660
Open 3.700 Yesterday's Close 3.700
Buy Price 3.660 Sell Price 3.670
Buy Volume ('00) 720 Sell Volume ('00) 1,038
Cumulative Volume ('00) 8,280 Cumulative Value 3,047,359
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.20048 Trailing EPS (MYR) e 1.24303 NAV (MYR) b 1.5844
PE a 18.256 Trailing PE f 2.944 Price / NAV b 2.3100
Dividend (MYR) d - Cash In Hand (MYR) g 1.5228 Issued & Paid-up Shares c 2,617,639,000
Dividend Yield (%) d - Price / Cash In Hand g 2.403 Treasury Shares h 102,981,000
Beta - 75 Daysi 1.821 R-Squared - 75 Days(%)i 6.41 Market Cap (M) 9,580.559
Beta - 500 Daysi 1.468 R-Squared - 500 Days (%)i 8.42 Enterprise Value (M) 5,986.336
Piotroski F Score 8 Exchange Code 7106 Par Value ( MYR ) n.a.
52 Weeks Volatility (%) 94.75 6-Month VWAP 5.252 Free Float (%) 57.4
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE / FTSE Bursa Malaysia EMAS Index / FTSE Bursa Malaysia EMAS Shariah Index / FTSE Bursa Malaysia Hijrah Shariah Index / FTSE Bursa Malaysia KLCI Index / FTSE Bursa Malaysia Top 100 Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 20 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 20 May 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SUPERMX Bursa 9,580.559 18.256 2.944 2.3100 -
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 8,616.240 13.551 5.067 4.3738 1.650
Medical Specialties Bursa 12,701.515 14.768 5.179 4.6828 1.264
Index BM HEALTH CARE Bursa 8,673.207 21.399 8.102 3.1749 1.309
FTSE Bursa Malaysia EMAS Index Bursa 5,325.431 38.044 25.706 1.3448 2.480
FTSE Bursa Malaysia EMAS Shariah Index Bursa 4,676.147 39.571 21.271 1.5836 2.216
FTSE Bursa Malaysia Hijrah Shariah Index Bursa 17,740.459 25.928 18.147 1.8363 2.586
FTSE Bursa Malaysia KLCI Index Bursa 34,075.711 25.938 17.640 1.6746 2.577
FTSE Bursa Malaysia Top 100 Index Bursa 14,085.227 33.654 22.305 1.5904 2.340
Local Peer TOPGLOV Bursa 37,411.748 21.347 4.364 5.4401 2.570
Local Peer HARTA Bursa 28,481.619 9.871 9.871 5.7251 -
Local Peer RGTBHD Bursa 254.580 51.181 18.841 2.4575 0.680
Local Peer ADVENTA Bursa 213.900 - - 3.9503 -
Local Peer LKL Bursa 170.033 39.578 48.973 1.4052 -
Global Peer ABBOTT LABORATORIES NYSE 195,556.809 43.719 34.332 5.8267 1.386
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 184,102.176 28.879 23.233 5.2514 0.190
Global Peer DANAHER CORP NYSE 174,567.902 49.734 49.734 4.6989 0.293
Global Peer MEDTRONIC PLC NYSE 168,201.908 46.645 46.645 3.2706 1.856
Global Peer INTUITIVE SURGICAL INC NASDAQ 103,298.765 97.397 88.034 10.1737 -
Global Peer STRYKER CORP NYSE 96,598.187 60.412 68.607 7.1544 0.917
Global Peer BECTON DICKINSON & CO NYSE 69,877.989 91.106 42.609 2.8149 1.328
Global Peer EDWARDS LIFESCIENCES CORP NYSE 62,250.729 75.602 73.150 13.3630 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 60,786.530 - 425.081 3.8671 -
Global Peer IDEXX LABORATORIES INC NASDAQ 50,508.347 86.817 74.915 71.8780 -
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), NOVOCURE LTD (NASDAQ), WATERS CORP (NYSE), STERIS PLC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), INSULET CORPORATION (NASDAQ), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), HOLOGIC INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), MICROPORT (HKEx), ABIOMED INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), MASIMO CORPORATION (NASDAQ), COCHLEAR LTD (ASX), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), WEIGAO GROUP (HKEx), Top Glove (SGX), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), STAAR SURGICAL CO (NASDAQ), SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NEVRO CORP (NYSE), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), NEOGEN CORP (NASDAQ), CARDIOFLOW-B (HKEx), QUIDEL CORP (NASDAQ), CAREDX INC (NASDAQ), INARI MEDICAL INC (NASDAQ), ICU MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), VENUS MEDTECH-B (HKEx), GLAUKOS CORPORATION (NYSE), ATRICURE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), INMODE LTD (NASDAQ), HAEMONETICS CORP (NYSE), VERICEL CORP (NASDAQ), AXONICS INC (NASDAQ), LIFETECH SCI (HKEx), PEIJIA-B (HKEx), HESKA CORP (NASDAQ), BUTTERFLY NETWORK INC (NYSE), OUTSET MEDICAL INC (NASDAQ), AVANOS MEDICAL INC (NYSE), KANGJI MEDICAL (HKEx), ESTABLISHMENT LABS HLDGS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AK MEDICAL (HKEx), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), INOGEN INC (NASDAQ), EARGO INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), NANOSONICS LIMITED (ASX), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), CIRC (HKEx), DERMTECH INC (NASDAQ), CHUNLI MEDICAL (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), CRYOLIFE INC (NYSE), ATRION CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), 908 DEVICES INC (NASDAQ), SI BONE INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), BIOVENTUS INC (NASDAQ), MODERN DENTAL (HKEx), CERUS CORP (NASDAQ), NATUS MEDICAL INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VIEWRAY INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), KDL MEDICAL (HKEx), AXOGEN INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), CUTERA INC (NASDAQ), BASECARE-B (HKEx), TRANSMEDICS GROUP INC (NASDAQ), SURMODICS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ANTARES PHARMA INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), STEREOTAXIS INC (NYSE American), TALIS BIOMEDICAL CORP (NASDAQ), VAPOTHERM INC (NYSE), NEUROPACE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ZYNEX INC (NASDAQ), PAVMED INC (NASDAQ), SOLITON INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), ONCOCYTE CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), ACUTUS MEDICAL INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SIENTRA INC (NASDAQ), NEURONETICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), QUOTIENT LTD (NASDAQ), MISONIX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), Medtecs Intl (SGX), PROFOUND MED CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), IRADIMED CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), YESTAR HEALTH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), DARIOHEALTH CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), CORMEDIX INC (NASDAQ), INVACARE CORP (NYSE), UGHealthcare (SGX), NEMAURA MEDICAL INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), AROA BIOSURGERY LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), CONFORMIS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), INTRICOM CORP (NASDAQ), LUCIRA HEALTH INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), CYCLOPHARM LIMITED (ASX), TELA BIO INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), PW MEDTECH (HKEx), EMVISION MEDICAL DEVICES LTD (ASX), VINCENT MED (HKEx), ENLIVEX THERAPEUTICS LTD (NASDAQ), SOMNOMED LIMITED (ASX), OPTISCAN IMAGING (ASX), VENUS CONCEPT INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), IMPEDIMED LIMITED (ASX), FONAR CORP (NASDAQ), ALPHA PRO TECH (NYSE American), IRIDEX CORP (NASDAQ), MICRO-X LTD (ASX), CHECK-CAP LTD (NASDAQ), CELSION CORPORATION (NASDAQ), BIOLASE INC (NASDAQ), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), AVINGER INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LENSAR INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), NEPHROS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), ELECTROMED INC (NYSE American), SDI LTD (ASX), ROCKWELL MEDICAL INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), APPLIED UV INC (NASDAQ), ELECTROCORE INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), CARDIEX LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEOVASC INC (NASDAQ), YUNNAN ENERGY (HKEx), RESONANCE HEALTH LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), Biolidics (SGX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), COMPUMEDICS (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BIOMERICA INC (NASDAQ), INSPIREMD INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), DAXOR CORP (NYSE American), RESPIRI LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), XTANT MEDICAL HLDGS INC (NYSE American), Yunnan Energy (SGX), TENAX THERAPEUTICS INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ADHERIUM LIMITED (ASX), NUWELLIS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), NANOVIBRONIX INC (NASDAQ), DYNATRONICS CORP (NASDAQ), LIFE HEALTHCARE (HKEx), ALLEGRA ORTHOPAEDICS LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), LBT INNOVATIONS LTD (ASX), USCOM LTD (ASX), OVENTUS MEDICAL LTD (ASX), CYANOTECH CORP (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), METALICITY LIMITED (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), Annica (SGX), DORSAVI LTD (ASX), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.210
-5.43 %
10 Days --0.440
-10.73 %
20 Days 0.130-1.223
-22.38 %
Medium Term Return 3 Months 0.130-0.571
-10.42 %
6 Months 0.168-3.256
-44.65 %
1 Year 0.168+0.153
+9.15 %
Long Term Return 2 Years 0.168+2.848
+371.43 %
3 Years 0.203+2.692
+299.07 %
5 Years 0.318+3.147
+675.44 %
Annualised Return Annualised --
+50.63 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 3.161 - 11.886 Change From 1 Year Low +0.499 % Change From 1 Year Low (%) +15.78
Change From 1 Year High -8.226 % Change From 1 Year High (%) -69.21
2 Years Range 0.627 - 11.886 Change From 2 Years Low +3.033 % Change From 2 Years Low (%) +483.36
Change From 2 Years High -8.226 % Change From 2 Years High (%) -69.21
5 Years Range 0.411 - 11.886 Change From 5 Years Low +3.249 % Change From 5 Years Low (%) +790.51
Change From 5 Years High -8.226 % Change From 5 Years High (%) -69.21
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Supermax Corporation Berhad is a leading international manufacturer, distributor and marketer of high quality medical gloves. Established in 1987, its founders started a trading business to distribute latex gloves and eventually ventured into the manufacturing of latex gloves in 1989. Today, the Supermax Group has eight factories manufacturing various types of latex gloves, which are exported to over 145 countries around the world, such as the United States of America, European Union, Middle East, Asia and South Pacific countries.



IPO Performance

Listing Date 07 Aug 2000 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) 6.10 Public Offer Subscription Rate (x) -
IPO Price (MYR) 2.000 First Day Close (MYR) 1.626 First Week Close (MYR) 1.291
Current vs IPO Price (%) +83.00 First Day Gain (%) -18.70 First Week Gain (%) -35.45

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Jun 2019 Part 1(1.54 MB)
Annual Report 2018 Jun 2018 Part 1(2.15 MB)
Part 2(0.62 MB)
Annual Report 2017 Jun 2017 Part 1(0.86 MB)
Annual Report 2016 Jun 2016 Part 1(2.06 MB)
Annual Report 2014 Dec 2014 Part 1(1.47 MB)
Annual Report 2013 Dec 2013 Part 1(1.93 MB)
Part 2(0.29 MB)
Annual Report 2012 Dec 2012 Part 1(2.78 MB)
Annual Report 2011 Dec 2011 Part 1(2.70 MB)
Annual Report 2010 Dec 2010 Part 1(2.25 MB)
Annual Report 2009 Dec 2009 Part 1(1.39 MB)
Part 2(0.05 MB)
Annual Report 2008 Dec 2008 Part 1(1.00 MB)
Annual Report 2007 Dec 2007 Part 1(0.84 MB)
Annual Report 2006 Dec 2006 Part 1(3.19 MB)
Annual Report 2005 Dec 2005 Part 1(1.39 MB)
Part 2(0.54 MB)
Annual Report 2004 Dec 2004 Part 1(1.03 MB)
Part 2(0.20 MB)
Part 3(0.24 MB)
Annual Report 2003 Dec 2003 Part 1(0.74 MB)
Part 2(0.23 MB)
Annual Report 2002 Dec 2002 Part 1(0.64 MB)
Annual Report 2001 Dec 2001 Part 1(0.74 MB)
Part 2(0.63 MB)
Part 3(1.08 MB)
Part 4(0.51 MB)
Part 5(1.29 MB)
Part 6(1.72 MB)
Annual Report 2000 Dec 2000 Part 1(0.49 MB)
Part 2(0.85 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
16 Jun 2021 3.740 3.740 3.660 3.700 6,940,600 3.6959
15 Jun 2021 3.750 3.780 3.690 3.740 8,576,500 3.7213
14 Jun 2021 3.880 3.950 3.710 3.720 16,413,200 3.8218
11 Jun 2021 3.820 3.850 3.700 3.710 13,195,300 3.7414
10 Jun 2021 3.870 3.930 3.810 3.820 11,478,300 3.8566
09 Jun 2021 3.820 3.990 3.800 3.870 15,297,500 3.8972
08 Jun 2021 3.920 3.920 3.800 3.820 14,269,400 3.8313
04 Jun 2021 4.000 4.050 3.900 3.920 15,206,400 3.9519
03 Jun 2021 4.110 4.160 3.970 4.010 12,130,600 4.0322
02 Jun 2021 4.050 4.180 4.000 4.100 11,316,700 4.0916
01 Jun 2021 4.130 4.160 3.970 4.030 12,595,200 4.0218
31 May 2021 4.160 4.350 4.110 4.130 11,468,100 4.1923
28 May 2021 4.340 4.340 4.240 4.240 11,655,500 4.2681
27 May 2021 4.440 4.440 4.270 4.370 25,131,000 4.3457
25 May 2021 4.490 4.490 4.310 4.450 22,077,900 4.3711
24 May 2021 4.670 4.670 4.450 4.490 16,723,200 4.5387
21 May 2021 4.688 4.795 4.543 4.630 21,489,292 4.6410
20 May 2021 4.893 4.961 4.679 4.718 31,631,999 4.8311
19 May 2021 4.533 4.922 4.533 4.883 39,736,233 4.7601
18 May 2021 4.552 4.611 4.474 4.513 9,956,625 4.5324
17 May 2021 4.620 4.688 4.494 4.513 16,833,951 4.5716
12 May 2021 4.474 4.669 4.474 4.640 14,094,740 4.5908
Summary
Current 2 Weeks
(02 Jun 2021 to 16 Jun 2021)
4.050 4.180 3.660 3.700 124,824,500 -
Previous 2 Weeks
(18 May 2021 to 01 Jun 2021)
4.552 4.611 3.660 4.030 202,465,049 -
4 Weeks from
(15 Apr 2021 to 17 May 2021)
4.523 5.077 3.660 4.513 817,922,520 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.